Literature DB >> 8916709

Cost effectiveness of lowering cholesterol. Full treatment of the costs and benefits is needed.

A S Wierzbicki, T M Reynolds.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8916709      PMCID： PMC2352460          DOI： 10.1136/bmj.313.7065.1143

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease.

Authors:  J L Megnien; J Levenson; A Simon
Journal:  Lancet       Date:  1996-02-17       Impact factor: 79.321

2.  Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease.

Authors:  A S Wierzbicki; T M Reynolds
Journal:  Lancet       Date:  1996-02-17       Impact factor: 79.321

3.  Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.

Authors:  P D Pharoah; W Hollingworth
Journal:  BMJ       Date:  1996-06-08

4.  Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)

Authors:  B Jönsson; M Johannesson; J Kjekshus; A G Olsson; T R Pedersen; H Wedel
Journal:  Eur Heart J       Date:  1996-07       Impact factor: 29.983

5.  Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.

Authors:  T R Pedersen; J Kjekshus; K Berg; A G Olsson; L Wilhelmsen; H Wedel; K Pyörälä; T Miettinen; T Haghfelt; O Faergeman; G Thorgeirsson; B Jönsson; J S Schwartz
Journal:  Circulation       Date:  1996-05-15       Impact factor: 29.690

6.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

7.  Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease.

Authors:  I U Haq; P R Jackson; W W Yeo; L E Ramsay
Journal:  Lancet       Date:  1995-12-02       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.